A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Case Medical Research ◽

10.31525/ct1-nct03901963 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Minimal Residual Disease ◽

Maintenance Treatment ◽

Stem Cell Transplant ◽

Residual Disease ◽

Autologous Stem Cell Transplant ◽

Cell Transplant ◽

Newly Diagnosed ◽

Minimal Residual

Download Full-text

Myeloma Canada Research Network (MCRN) 001 Trial with Intravenous (IV) Busulfan + Melphalan (BuMel) as Enhanced Conditioning, followed by Lenalidomide (Len) Maintenance in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts): First Results of Minimal Residual Disease (MRD) and Hevylite(TM) Chain (HLC) Assays at Day 100 Post Autologous Stem Cell Transplant (ASCT)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2015.07.190 ◽

2015 ◽

Vol 15 ◽

pp. e51-e52

Author(s):

D. Reece ◽

G.P. Rodriguez ◽

M. Pantoja ◽

H. Paul ◽

C.P. Venner ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplant ◽

Residual Disease ◽

Autologous Stem Cell Transplant ◽

Research Network ◽

Cell Transplant ◽

Newly Diagnosed ◽

First Results ◽

Minimal Residual

Download Full-text

PS1413 INCIDENCE OF NEGATIVE MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA PATIENTS AFTER AUTOLOGOUS STEM CELL TRANSPLANT

10.1097/01.hs9.0000563928.27154.17 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 649-650

Author(s):

C. Afonso ◽

A. Roque ◽

T. Nascimento ◽

A.B. Sarmento ◽

C. Geraldes ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Minimal Residual Disease ◽

Stem Cell Transplant ◽

Residual Disease ◽

Autologous Stem Cell Transplant ◽

Cell Transplant ◽

Minimal Residual

Download Full-text

Autologous stem cell transplant in acute lymphoblastic leukemia: prognostic impact of pre-transplant minimal residual disease

Leukemia & Lymphoma ◽

10.1080/10428194.2018.1468895 ◽

2018 ◽

Vol 60 (1) ◽

pp. 274-276

Author(s):

Saveria Capria ◽

Sara Pepe ◽

Silvia Maria Trisolini ◽

Anna Maria Testi ◽

Antonella Vitale ◽

...

Keyword(s):

Stem Cell ◽

Acute Lymphoblastic Leukemia ◽

Minimal Residual Disease ◽

Stem Cell Transplant ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Autologous Stem Cell Transplant ◽

Prognostic Impact ◽

Cell Transplant ◽

Minimal Residual

Download Full-text

Minimal residual disease and log‐reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myeloma

Cytometry Part B Clinical Cytometry ◽

10.1002/cyto.b.21755 ◽

2018 ◽

Vol 96 (3) ◽

pp. 195-200 ◽

Author(s):

Giovanni Rossi ◽

Antonietta Pia Falcone ◽

Maria Marta Minervini ◽

Giovanni Pio De Cillis ◽

Chiara De Waure ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplant ◽

Plasma Cells ◽

Residual Disease ◽

Autologous Stem Cell Transplant ◽

Cell Transplant ◽

Younger Patients ◽

Log Reduction ◽

Minimal Residual

Download Full-text

OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)02089-9 ◽

2021 ◽

Vol 21 ◽

pp. S10

Author(s):

Ruth De Tute ◽

Charlotte Pawlyn ◽

David Cairns ◽

Faith Davies ◽

Andy Rawstron ◽

...

Keyword(s):

Stem Cell ◽

Minimal Residual Disease ◽

Stem Cell Transplant ◽

Residual Disease ◽

Prognostic Significance ◽

Autologous Stem Cell Transplant ◽

Cell Transplant ◽

Minimal Residual

Download Full-text

Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen

Haematologica ◽

10.3324/haematol.2015.128215 ◽

2015 ◽

Vol 101 (2) ◽

pp. e69-e71 ◽

Author(s):

R. M. de Tute ◽

A. C. Rawstron ◽

W. M. Gregory ◽

J. A. Child ◽

F. E. Davies ◽

...

Keyword(s):

Stem Cell ◽

Minimal Residual Disease ◽

Stem Cell Transplant ◽

Residual Disease ◽

Autologous Stem Cell Transplant ◽

Cell Transplant ◽

Induction Regimen ◽

Minimal Residual

Download Full-text

OAB-003: CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed (NDTE) multiple myeloma (MM)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)02077-2 ◽

2021 ◽

Vol 21 ◽

pp. S2-S3

Author(s):

Rakesh Popat ◽

William Wilson ◽

Marquita Camilleri ◽

Ruth De Tute ◽

Gavin Pang ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplant ◽

Autologous Stem Cell Transplant ◽

Cell Transplant ◽

Newly Diagnosed

Download Full-text

Lenalidomide and low-dose dexamethasone (Ld) is equivalent to Ld plus autologous stem cell transplant (ASCT) in newly diagnosed multiple myeloma (NDMM): Results of a randomized, phase III trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8530 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8530-8530

Author(s):

Suzanne Lentzsch ◽

Susanna Miao ◽

Jordan Mark Schecter ◽

Kent A. Griffith ◽

Daniel Paul Normolle ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Low Dose ◽

Stem Cell Transplant ◽

Autologous Stem Cell Transplant ◽

Phase Iii ◽

Cell Transplant ◽

Newly Diagnosed ◽

Phase Iii Trial

Download Full-text

Geriatric assessment (GA) and eligibility for autologous stem cell transplant (ASCT) in older adults with newly diagnosed multiple myeloma (MM).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e20525 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e20525-e20525 ◽

Author(s):

Tanya Marya Wildes ◽

Sascha Alexander Tuchman ◽

Brittany Depp ◽

Ling Chen ◽

Keith Stockerl-Goldstein ◽

...

Keyword(s):

Older Adults ◽

Multiple Myeloma ◽

Stem Cell ◽

Geriatric Assessment ◽

Stem Cell Transplant ◽

Autologous Stem Cell Transplant ◽

Cell Transplant ◽

Newly Diagnosed

Download Full-text

Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?

Haematologica ◽

10.3324/haematol.2018.208587 ◽

2019 ◽

Vol 104 (8) ◽

pp. 1521-1531 ◽

Author(s):

Brian Ball ◽

Eytan M. Stein

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Minimal Residual Disease ◽

Myeloid Leukemia ◽

Stem Cell Transplant ◽

Residual Disease ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Minimal Residual ◽

Download Full-text